Prestige Consumer Healthcare (PBH) Interest Expenses (2010 - 2026)
Prestige Consumer Healthcare (PBH) posted quarterly Interest Expenses of $26.6 million for Q4 2025, up 70.5% year-over-year from $15.6 million in Q4 2024, and down 11.04% quarter-over-quarter from $29.9 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Interest Expenses (2010 - 2026) Analysis & Trends
Prestige Consumer Healthcare's Interest Expenses history runs 16 years deep, the most recent figure standing at $26.6 million for Q4 2025.
- In Q4 2025, Interest Expenses rose 70.5% year-over-year to $26.6 million; the TTM figure through Dec 2025 stood at $26.6 million (up 70.5% YoY), while the FY2025 annual figure was $85.7 million, up 35.56% from the prior year.
- Interest Expenses for Q4 2025 stood at $26.6 million, down from $29.9 million in the prior quarter.
- The five-year high for Interest Expenses was $33.4 million in Q1 2021, with the low at -$46.7 million in Q1 2024.
- The 5-year median for Interest Expenses is $17.3 million (2021), against an average of $11.4 million.
- The sharpest annual moves came in 2021 and 2022: Interest Expenses jumped 151.48% in 2021, then sank 203.64% in 2022.
- Prestige Consumer Healthcare's Interest Expenses stood at $22.8 million in 2021, then dropped by 11.14% to $20.3 million in 2022, then declined by 18.31% to $16.6 million in 2023, then dropped by 5.83% to $15.6 million in 2024, then surged by 70.5% to $26.6 million in 2025.
- Business Quant data shows PBH's Interest Expenses at $26.6 million in Q4 2025, $29.9 million in Q3 2025, and $28.5 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.46 Bn | 2.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.05 Mn |
| Mar 31, 2026 | 6.05 Mn |
| Dec 31, 2025 | 26.61 Mn |
| Dec 31, 2025 | 26.61 Mn |
| Sep 30, 2025 | 29.91 Mn |
| Sep 30, 2025 | 29.91 Mn |
| Jun 30, 2025 | 28.55 Mn |
| Jun 30, 2025 | 28.55 Mn |
| Mar 31, 2025 | 10.38 Mn |
| Mar 31, 2025 | 10.38 Mn |
| Dec 31, 2024 | 15.61 Mn |
| Dec 31, 2024 | 15.61 Mn |
| Sep 30, 2024 | 15.70 Mn |
| Sep 30, 2024 | 15.70 Mn |
| Jun 30, 2024 | 14.21 Mn |
| Jun 30, 2024 | 14.21 Mn |
| Mar 31, 2024 | -46.70 Mn |
| Mar 31, 2024 | -46.70 Mn |
| Dec 31, 2023 | 16.58 Mn |
| Dec 31, 2023 | 16.58 Mn |